Scholars Central

Conference abstract

Developments in bacterial kill using blue light emitting diodes (LEDs)

Authors: Violet V Bumah

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background and Objective: The increasing burden of multiple drug resistant bacteria underscores the need to find innovative therapeutics for bacterial infection in clinical situations. Our team has shown that blue light is antimicrobial and has the potential to speed wound repair 1,2. To advance our line of work, we utilized a breakthrough technology, the CareWear® wound patch, emitting blue 450 nm light, to treat P. acnes and MRSA in vitro. Methods: Bacteria were grown in their respective media aerobically/anaerobically at 37°C until they reached logarithmic growth phase. Concentrations of 1x106 colony forming units (CFU) /mL of Propionibacterium acnes (P. acnes) and methicillinresistant Staphylococcus aureus (MRSA) were plated and bacteria assigned to two groups; control and treated. Various irradiation protocols (average irradiance of 2, 3.5 and 4.5 mW/cm2 in continuous wave mode and 2 or 3.5 mW/cm2 in pulsed modes; and fluences ranging from 5 ??? 60 J/cm2) were applied after which plates were incubated at 37°C, colonies photographed, counted and percent survival computed. Results: CareWear® 450 nm light patches, effectively suppressed the growth of P. acnes and MRSA at low levels of optical irradiance and fluence when applied in specific pulsed modes and treatment sequences. Levels as low as 5 J/cm2 demonstrated 100% bacterial kill rates in vitro. This finding is a significant improvement over similar continuous wave blue light devices, which require energy levels greater than 60 J/cm2 to achieve comparable results. Moreover, it shows that, for maximum antimicrobial effect, it is not necessary to irradiate at the relatively high energy densities of 50 ??? 60 J/cm2 or higher as reported in our previous studies and those of others. Conclusion: Blue light inactivates a host of bacteria, including the notoriously deadly MRSA and other drug-resistant bacteria. Our results show that bacterial clearance is achievable at much lower energy fluences using the new technology and protocol, which is not only more effective but naturally safer for patients and others.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Clinical Microbiology: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Microbiology: Open Access
  • SubjectMicrobiology
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Violet V Bumah”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels